Q1 2026 Holdings
Filed 2026-05-14 | 38 holdings | $158.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Plains GP Hldgs L P(PAGPEUR) | LTD PARTNR INT A | 72651A207 | $30.2M | 1,272,360 | 19.0% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $11.4M | 3,786,425 | 7.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $9.4M | 841,272 | 5.9% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $9.2M | 979,698 | 5.8% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $6.0M | 147,828 | 3.8% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $6.0M | 1,329,899 | 3.8% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $5.6M | 314,543 | 3.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $5.6M | 644,421 | 3.5% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $5.1M | 4,118,321 | 3.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.1M | 131,364 | 2.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.1M | 742,049 | 2.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.1M | 210,163 | 2.6% |
| Inventiva SA(IVA) | ADS | 46124U107 | $4.0M | 724,678 | 2.5% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $3.9M | 1,012,790 | 2.4% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $3.8M | 896,701 | 2.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $3.6M | 380,420 | 2.3% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $3.3M | 122,223 | 2.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $3.2M | 382,375 | 2.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $3.1M | 341,779 | 2.0% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.0M | 710,988 | 1.9% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $2.8M | 215,825 | 1.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.6M | 223,802 | 1.7% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $2.6M | 282,418 | 1.7% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $2.6M | 2,344,779 | 1.7% |
| Coherus Oncology Inc(CHRS) | COM | 19249H103 | $2.4M | 1,420,550 | 1.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.0M | 921,457 | 1.3% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $2.0M | 1,115,000 | 1.3% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $1.7M | 295,771 | 1.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.7M | 104,772 | 1.1% |
| Leonabio Inc(LONA) | COM | 04746L203 | $1.5M | 149,279 | 0.9% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.4M | 329,296 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $1.3M | 43,798 | 0.8% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $1.3M | 55,664 | 0.8% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.3M | 85,791 | 0.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.2M | 730,606 | 0.8% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $949.8K | 146,369 | 0.6% |
| Connect Biopharma Hldgs LTD(CNTB) | SHS | G23549101 | $553.9K | 209,493 | 0.3% |
| Satellos Bioscience Inc(MSLE) | COM | 80401L803 | $57.1K | 10,145 | 0.0% |